3D Neuronal Models Using Self-Assembling Peptide Scaffolds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current neuronal models, both 2D and 3D, face limitations such as exposure to unnatural mechanical cues, reliance on animal-derived scaffolds, and complex preparation processes, making them unsuitable for applications like cellular replacement therapies and drug testing for neurodegenerative disorders.
Innovation Solution
A functional 3D neuronal model is developed using ultrashort self-assembling peptide scaffolds, which are created through 3D bioprinting with neurons and peptides as bioinks, providing a more natural environment for cell growth and differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If 2D neuronal models are used, then the preparation process is simple, but the mechanical cues are unnatural and do not reflect in vivo conditions
Solution Approach 1:
The patent transitions from 2D neuronal culture on plastic surfaces to 3D neuronal models embedded in self-assembling peptide hydrogels. This dimensional change provides natural 3D mechanical cues and spatial organization that mimic in vivo conditions, improving physiological relevance while maintaining preparation simplicity through the self-assembly properties of the peptide scaffolds.
2Strength
If animal-derived scaffolds are used, then the structural support is adequate, but the immunogenicity and reproducibility are compromised
Solution Approach 1:
The patent employs synthetic self-assembling peptide scaffolds that can be easily synthesized, standardized, and reproduced without batch-to-batch variability inherent in animal-derived materials. These peptide hydrogels provide adequate structural support while being immunologically inert and highly reproducible, eliminating concerns about animal-derived contaminants and variability.
3Manufacturing precision
If complex preparation steps are used, then the model accuracy is improved, but the reproducibility and ease of use are reduced
Solution Approach 1:
The patent utilizes self-assembling peptide scaffolds that automatically organize into hydrogel structures with appropriate mechanical and biochemical properties without requiring complex crosslinking protocols, UV irradiation, or specialized bioreactors. The peptides self-assemble through non-covalent interactions, providing high model accuracy while maintaining simple, reproducible preparation procedures.
4Reliability
If external chemicals and growth factors are infused, then the neuronal differentiation is enhanced, but the system complexity and preparation time increase
Solution Approach 1:
The patent incorporates bioactive peptide sequences within the scaffold structure itself, allowing controlled release of differentiation-promoting signals through changes in peptide sequence, concentration, and hydrogel composition. This eliminates the need for complex external growth factor infusion systems while maintaining enhanced neuronal differentiation through intrinsic scaffold properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide scaffolds support high viability, proliferation, and maturation of neurons, enabling effective in vitro drug testing and potential cellular replacement therapies for neurological disorders, with improved reproducibility and reduced complexity in preparation.
Implementation Method 1
ultrashort self-assembling peptide scaffolds
Data Source
AI summary
The present invention relates to a functional 3D neuronal model based on ultrashort self-assembling peptide scaffolds in accordance with the present invention, and to a method of preparing such a model. The models are suitable for in vitro drug testing, cellular replacement therapies as well as other applications.